| Through talent and collective experience InVasc has created a multi-level drug strategy that has engendered an impressive number of novel drugs, contained within four drug platforms. Each of these platforms is founded upon a unique, naturally-occurring base. As naturally occurring derivatives these compounds have demonstrated lower levels of toxicities, and are likely to have magnified levels of efficacy.
|
 |
Emerging from one of the four platforms are two overwhelmingly positive compounds, INV-064 and INV-065, specific to the prevention and treatment of target organ complications in diabetic patients. Impressively, these compounds also show remarkable application in the control and treatment of hypertension, a disease often concomitant with diabetes. |
